Clinical study on management strategies and methods of adenomyosis after conservative operation

A prospective, multicenter and cohort study on avoid recurrence in adenomyosis after conservative surgery using various drugs

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPN-17012991

Enrollment

Unknown

Registered

2017-10-15

Start date

2018-05-23

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenomyosis

Interventions

Group A:unhandled control group

Group B:GnRHa

Group D:LNG-IUS

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pathological and clinical diagnosis indicate adenomyosis; women aged 18 to 45 years; with no steroid hormone treatment before surgery; healthy and non-pregnancy; be voluntory to this trial and sign consent form.

Exclusion criteria

Exclusion criteria: Participating in other clinical trials; with ovarian endometrioma and deep infiltration endometriosis; steroid hormone treatment within 3 months; with disorder in hematological Cardiovascular cerebrovascular systems and liver and renal function; can not tolerate surgery and medical treatment; unwilling to sign informed consent; unwilling to obey requirements of the research.

Design outcomes

Primary

Measure	Time frame
VRS&NRS;PBAC;	—

Secondary

Measure	Time frame
uterine size;lesion size;SF36;FSFI;FSH;LH;AMH;CA125;	—

Countries

China

Contacts

Public ContactWang Shixuan

Huazhong University of Science and Technology

shixuanwang@126.com+86 13995553319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026